Home » Stocks » YI

111, Inc. (YI)

Stock Price: $11.90 USD 3.41 (40.16%)
Updated Jan 22, 2021 4:00 PM EST - Market closed
Pre-market: $14.04 +2.14 (17.98%) Jan 25, 4:30 AM
Market Cap 980.08M
Revenue (ttm) 564.58M
Net Income (ttm) -71.37M
Shares Out 82.36M
EPS (ttm) -1.27
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 22
Last Price $11.90
Previous Close $8.49
Change ($) 3.41
Change (%) 40.16%
Day's Open 8.75
Day's Range 8.75 - 12.85
Day's Volume 5,822,333
52-Week Range 5.35 - 12.85

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
PRNewsWire - 1 month ago

SHANGHAI, Dec. 22, 2020 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading digital healthcare platform company committed to digitally connecting patients with medicine ...

Seeking Alpha - 2 months ago

111, Inc. (YI) CEO Junling Liu on Q3 2020 Results - Earnings Call Transcript

PRNewsWire - 2 months ago

SHANGHAI, Nov. 19, 2020 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading digital healthcare platform committed to digitally connecting patients with medicine and heal...

PRNewsWire - 3 months ago

SHANGHAI, Oct. 19, 2020 /PRNewswire/ -- On September 24, 111, Inc. (the "Company" or "111") entered into a strategic partnership (the "Partnership") with Bayer Healthcare Co. Ltd. ("Bayer Heal...

PRNewsWire - 3 months ago

SHANGHAI, Oct. 15, 2020 /PRNewswire/ -- On September 24, 111, Inc. (NASDAQ: YI) (the "Company" or "111") and Hainan Huluwa Pharmaceutical Group Co., Ltd. (SH: 605199) ("Huluwa Pharmaceutical")...

PRNewsWire - 3 months ago

SHANGHAI, Oct. 15, 2020 /PRNewswire/ -- On September 24, 111, Inc. (NASDAQ: YI) ("111") and Shanghai Uniondrug Information Technology Co., Ltd ("Shanghai Uniondrug") officially signed a strate...

PRNewsWire - 3 months ago

SHANGHAI, Sept. 30, 2020 /PRNewswire/ -- On September 24, 2020, 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading digital healthcare platform dedicating to digitally connecting patien...

PRNewsWire - 4 months ago

SHANGHAI, Sept. 4, 2020 /PRNewswire/ -- On August 25, 111, Inc.

Seeking Alpha - 5 months ago

111, Inc. (YI) CEO Junling Liu on Q2 2020 Results - Earnings Call Transcript

PRNewsWire - 5 months ago

SHANGHAI, Aug. 20, 2020 /PRNewswire/ -- 111, Inc.

PRNewsWire - 5 months ago

Completion of new capital injection in principal subsidiary Yao Fang Shanghai Initiation to list shares of principal subsidiary Yao Fang Shanghai on the STAR Market 111 firmly committed to mai...

PRNewsWire - 5 months ago

SHANGHAI, July 31, 2020 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a Company dedicated to digitally connecting patients with drugs and healthcare services in China, today...

Seeking Alpha - 8 months ago

111, Inc. (YI) CEO Junling Liu on Q1 2020 Results - Earnings Call Transcript

PRNewsWire - 8 months ago

SHANGHAI, May 21, 2020 /PRNewswire/ --111, Inc. ("111" or the "Company") (NASDAQ: YI), a Company dedicated to digitally connecting patients with drugs and healthcare services in China, today a...

Seeking Alpha - 10 months ago

111, Inc. (YI) CEO Junling Liu on Q4 2019 Results - Earnings Call Transcript

Seeking Alpha - 1 year ago

111, Inc.'s (YI) CEO Junling Liu on Q3 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

We highlight five small-cap ETFs and stocks that have outperformed in September. These could be excellent plays for investors should the same trends prevail.

Other stocks mentioned: HOV, KOOL, LXRX, MCF
Seeking Alpha - 1 year ago

111, Inc. (YI) CEO Junling Liu on Q2 2019 Results - Earnings Call Transcript

Seeking Alpha - 1 year ago

111, Inc's (YI) CEO Junling Liu on Q1 2019 Results - Earnings Call Transcript

Bloomberg Markets and Finance - 1 year ago

China's 111 Sees Boost From Healthcare Reform

One of China's leading online pharmacy and healthcare service providers says it will attract new partners as reforms take shape in the nation's healthcare market. 111 Inc. co-founder and Execu...

About YI

111, through its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2B and B2C. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services, such as online consultation services and e-prescription services to consumers. Its product portfolio comprises prescription and over-the counter drugs, such as western and traditional Chinese medicinal drugs; nu... [Read more...]

Industry
Pharmaceutical Retailers
Founded
2010
Stock Exchange
NASDAQ
Ticker Symbol
YI
Full Company Profile

Financial Performance

In 2019, 111, Inc.'s revenue was 3.95 billion, an increase of 121.28% compared to the previous year's 1.79 billion. Losses were -499.61 million, 31.4% more than in 2018.

Financial numbers in millions CNY.
Financial Statements

Analyst Forecasts

According to one analyst, the rating for 111, Inc. stock is "Strong Buy" and the 12-month stock price forecast is 12.00.

Price Target
$12.00
Analyst Consensus: Strong Buy